Rademacher Group LTD
This article was originally published in Start Up
Executive Summary
Scientists at Rademacher Group are trying to elucidate the molecular mechanisms of glucose control.
You may also be interested in...
Tackling Diabetes and Obesity
The growing incidence of these diseases, and their complexity, provide opportunities for a number of different approaches
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”
The New Antibodies Revolutionizing Medicine
Nucleic acid-based therapies are poised to revolutionize medicine – just as antibodies did thirty years ago.